Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study
- DOI
- 10.3390/curroncol33060320
- Published
- 2026-05-28
- Container
- Current Oncology
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol33060320,
title = {Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study},
author = {Mario Uccello and Abigail L. Gee and James A. Bennett and Helen L. Hazell and Manuel Ruiz-Echarri Rueda and Mark J. Beresford},
year = {2026},
journal = {Current Oncology},
doi = {10.3390/curroncol33060320},
url = {https://doi.org/10.3390/curroncol33060320}
}RIS
TY - JOUR TI - Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study AU - Mario Uccello AU - Abigail L. Gee AU - James A. Bennett AU - Helen L. Hazell AU - Manuel Ruiz-Echarri Rueda AU - Mark J. Beresford PY - 2026 JO - Current Oncology DO - 10.3390/curroncol33060320 UR - https://doi.org/10.3390/curroncol33060320 ER -
APA
Uccello, M., Gee, A. L., Bennett, J. A., Hazell, H. L., Rueda, M. R., & Beresford, M. J. (2026). Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study. Current Oncology. https://doi.org/10.3390/curroncol33060320
Source records
- crossref · retrieved 2026-09-25T18:46:43.779Z